Discover 2,717 paid clinical trials in Ontario. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Filter
1
Filter results
Results: 2,717
Inhaled Nitric Oxide for Cardiac Arrest in Pediatrics and Adults (iNOCAPA)
for
Cardiac Arrest
Location: Toronto
Sponsor: The Hospital for Sick Children
Sex: All
Age: 0 - 70+
Code: NCT05868109
Phase2, Recruiting
Pre-pectoral Versus Sub-pectoral Implant Placement in Immediate Breast Reconstruction
for
Mastectomy, Breast Cancer
Location: Ottawa
Sponsor: Ottawa Hospital Research Institute
Sex: Female
Age: 20 - 70+
Code: NCT03959709
Recruiting
Strategies for Optimal Lung Ventilation in ECMO for ARDS: The SOLVE ARDS Study
for
Respiratory Distress Syndrome, Adult
Location: Toronto
Sponsor: University of Toronto
Sex: All
Age: 16+
Code: NCT01990456
Recruiting
Chest Lymph Node Sampling in Patients With Advanced Lung Cancer to be Treated With Curative-intent Radiation Treatment
for
Non-Small Cell Lung Cancer
Location: Toronto, London
Sponsor: London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Sex: All
Age: 18+
Code: NCT04852588
Recruiting
A Study to Test Whether Vicadrostat in Combination With Empagliflozin Helps People With Heart Failure
for
Heart Failure
Location: Bridgeport CT, The Bronx NY, New York NY,
Sponsor: Boehringer Ingelheim
Sex: All
Age: 18+
Code: NCT06424288
Phase3, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Short-term Function and Pain After Treatment for Dupuytren's Disease
for
Dupuytren Disease
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: All
Age: 18+
Code: NCT02301078
Recruiting
Development of an Interactive Web-based Teaching Tool for in Vitro Fertilization (IVF) Patients
for
Education
Location: Ottawa
Sponsor: Ottawa Fertility Centre
Sex: Female
Age: 18+
Code: NCT01046188
Recruiting
Oncologist-Initiated Cancer Genetic Testing for Pancreatic Cancer Patients
for
Pancreatic Cancer
Location: Toronto
Sponsor: Sunnybrook Health Sciences Centre
Sex: All
Age: 18+
Code: NCT04316507
Recruiting
Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab Versus Pembrolizumab Alone in Metastatic Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥ 50% (MK-2870-007)